Ads
related to: vertex pharmaceuticals
Search results
Why Is Arcturus Therapeutics Stock Trading Higher On Tuesday? - Arcturus Therapeutics (NASDAQ:ARCT)
Benzinga· 6 days agoOn Tuesday, Arcturus Therapeutics Holdings Inc. ARCT announced that it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in cystic fibrosis (CF) for ARCT-032 at ...
The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
Investor's Business Daily· 6 days agoWilliam Blair analyst Myles Minter noted that the results are encouraging, but questions remain. It...
Nvidia CEO, CrowdStrike, Jobs Report Headline Investing Action Plan
Investor's Business Daily· 3 days agoHere's your Investing Action Plan for the week ahead. Nvidia CEO Jensen Huang will make a key speech...
Evercore ISI cuts Editas Medicine stock target By Investing.com
Investing.com· 4 days agoOn Thursday, Evercore ISI adjusted its outlook on Editas Medicine (NASDAQ:EDIT), a biotechnology...
Stock market today: Wall Street drifts in quiet trading after returning from a 3-day weekend
WLNS Lansing· 6 days agoNEW YORK (AP) — Wall Street is listless on Tuesday, coming back from a three-day weekend, and is...
Stock market today: Wall Street drifts in quiet trading after returning from a 3-day weekend
WRBL Columbus· 6 days agoNEW YORK (AP) — Wall Street is listless on Tuesday, coming back from a three-day weekend, and is...
Stock market today: Asian shares decline after a mixed post-holiday session on Wall Street
Associated Press Finance via Yahoo Finance· 7 days agoAsian shares were mostly lower Wednesday after a mixed session on Wall Street following a three-day...
Nvidia Surges as Nasdaq Hits New High
newser· 6 days agoBut some technology stocks remained particularly strong. Nvidia was leading the way and jumped 7.1% to bring its gain for the year so far to a whopping...
ASX 200 set to dip; Nvidia soars overnight; CPI on tap By Investing.com
Investing.com· 6 days agoASX 200 set to dip; Nvidia soars overnight; CPI on tap
Calliditas Therapeutics’ stock surges after $1.1 billion takeover bid
Market Watch· 6 days agojumped more than 70% premarket on Tuesday after a nearly $1.1 billion takeover bid from Japanese...
